Sign in

CIK 0001104506

  • Large accelerated filer
Ticker
INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
EIN
541972729
Phone
+1 908-977-9900
Business address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,100,000
in 1 filing

Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Brennan David R −$3.1M Director sold 39% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-17 Lewis William Chair and CEO Exercise or conversion · Stock Option (right to buy) 10b5-1 −6,830 191,310
2025-03-03 Lewis William Chair and CEO Exercise or conversion 10b5-1 +18,750 $22.76 $427K 352,936
2025-03-03 Lewis William Chair and CEO Sale 10b5-1 −7,317 $76.24 $558K 345,619
2025-03-03 Lewis William Chair and CEO Sale 10b5-1 −758 $77.75 $59K 344,861
2025-03-03 Lewis William Chair and CEO Sale 10b5-1 −7,763 $78.61 $610K 337,098
2025-03-03 Lewis William Chair and CEO Sale 10b5-1 −2,785 $79.43 $221K 334,313
2025-03-03 Lewis William Chair and CEO Sale 10b5-1 −127 $80.90 $10K 334,186
2025-03-03 Lewis William Chair and CEO Exercise or conversion 10b5-1 +6,830 $10.85 $74K 240,754
2025-03-03 Lewis William Chair and CEO Sale 10b5-1 −2,671 $76.23 $204K 238,083
2025-03-03 Lewis William Chair and CEO Sale 10b5-1 −1,486 $78.20 $116K 236,597
2025-03-03 Lewis William Chair and CEO Sale 10b5-1 −2,250 $78.97 $178K 234,347
2025-03-03 Lewis William Chair and CEO Sale 10b5-1 −377 $79.73 $30K 233,970
2025-03-03 Lewis William Chair and CEO Sale 10b5-1 −46 $80.90 $4K 233,924
2025-03-03 Lewis William Chair and CEO Exercise or conversion · Stock Option (right to buy) 10b5-1 −18,750 18,750
2025-03-03 Lewis William Chair and CEO Exercise or conversion · Stock Option (right to buy) 10b5-1 −6,830 198,140
2025-02-25 SHAROKY MELVIN MD Director Gift −1,443 296,734
2025-02-25 SHAROKY MELVIN MD Director Gift +481 5,180
2025-02-25 SHAROKY MELVIN MD Director Gift +481 3,481
2025-02-25 SHAROKY MELVIN MD Director Gift +481 4,764
2025-02-18 Lewis William Chair and CEO Exercise or conversion 10b5-1 +18,750 $22.76 $427K 352,936

Page 28 of 42 · 826 trades